Compare Sana Biotechnology Inc (SANA) vs J M Smucker Co (SJM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs J M Smucker Co — how do they compare? Sana Biotechnology Inc trades at $2.8 (market cap $836.71M), while J M Smucker Co trades at $119.43 (market cap $12.76B). The key difference: J M Smucker Co is far larger — about 15.3× Sana Biotechnology Inc's market cap, and J M Smucker Co pays a 3.75% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sana Biotechnology Inc for 23 Days and J M Smucker Co for 74 Days on average.
| SANA | SJM | |
|---|---|---|
Market Cap | $836.71M | $12.76B |
Volume | 4,507,444 | 1,300,545 |
Sector | Health | Consumer Staples |
52-Week High | $5.92 | $132.34 |
52-Week Low | $2.68 | $89.53 |
Typical Hold Time | 23 Days | 74 Days |
Enterprise Value | $749.96M | $19.61B |
Dividend Yield | — | 3.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $2.79, up 2.57% today, but faces significant fundamental challenges with no revenue, negative EBITDA of -$192.96M, and deeply negative ROE of -152.87%. Technical indicators show bearish momentum with moving averages signaling sell pressure, though oscillators remain neutral. The company continues to burn cash with -$55.33M net cash flow in 2025, relying on financing activities to fund operations while advancing its cell therapy pipeline through multiple investor presentations.
Despite 82% analyst buy ratings and a $9.50 consensus price target, SANA represents a high-risk biotech investment with substantial execution risk. The absence of revenue, persistent losses, and cash burn require careful monitoring of clinical milestones. Near-term catalysts depend on pipeline progress, but shareholders face dilution risk from continued financing needs amid challenging technical conditions.
SJM trades at $119.83, up 3.36% today, with a bullish technical signal and recent earnings beats. The company reported strong Q2 2026 EPS of $3.24 versus $2.22 expected, though 2025 net income was negative $1.23B. Valuation ratios include a P/E of 55.8 and P/S of 1.39, with analyst consensus price target at $138.23.
Outlook is positive with raised 2027 guidance, but risks include volatile profitability and high debt. The stock offers a dividend yield from the upcoming $1.12 payment, supported by institutional buying. Earnings momentum and brand strength provide upside, yet margin pressures and competitive threats remain key watchpoints.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →
